This analyst note examines the gap between OpenAI’s valuation and its underlying fundamentals ahead of a potential IPO.

This analyst note examines the shifting dynamics reshaping venture capital in consumer AI and what they signal for investors.

This analyst notes looks at the factors that will drive the growth of the North American VC market.

This analyst note examines SpaceX’s S-1 filing ahead of its expected record-breaking IPO, analyzing the company’s AI-focused positioning against the economic reality of its business segments.

Operation Epic Fury reshaped PE/VC markets across aerospace, defense, energy, and construction. PitchBook breaks down winners, headwinds, and acquisition targets across seven sectors.

This analyst note examines how the largest power transaction on record signals a strategic shift toward grid infrastructure control in the AI datacenter build-out.

This analyst note examines the patent infringement lawsuit between two of the most prominent venture secondary platforms and its implications for the broader secondary market.

This analyst note examines how China’s AI venture market is consolidating around strategic sectors like enterprise software, compute hardware, and semiconductors amid a broader VC slowdown.

SPACs return after a 75% deSPAC index decline. The 2024 SEC overhaul tightened the rules, but with 25% of unicorns stalled since 2022, whether discipline follows structure remains the open question.

This analyst note introduces PitchBook’s 209-node AI taxonomy, designed to help investors and strategy officers navigate the shift from traditional software to AI-driven digital labor.

This analyst note examines the US venture secondary market’s record growth, its concentration risks, the impact of upcoming mega-IPOs, and structural shifts broadening access to private markets.

This analyst note examines how a prolonged liquidity crunch and AI’s valuation surge are reshaping LP co-investment strategies in US venture capital.

This analyst note examines how capital concentration, manager specialization, and the decline of leverage-driven returns are reshaping the private equity fundraising landscape.

81% of US physicians now use AI. We map a five-layer AI care delivery stack, profile dozens of companies, and project healthcare cost scenarios.

This analyst note examines OpenAI’s IPO readiness challenges, including infrastructure obligations, governance concerns, and competitive pressures that may delay its public listing.

Our Medtech Public Comp Sheet and Valuation Guide tracks stock performances, valuations, and market caps of key publicly traded medtech companies.

Mythos saturated every benchmark Anthropic threw at it. On USAMO alone, the score moved from 42.3% to 97.6%. This is not iteration; it is a different animal. Anthropic’s response to building it was to not sell it. The model that escaped its own sandbox, found vulnerabilities no human had caught in 27 years, and triggered an emergency meeting between the Treasury Secretary and the Fed Chair generates zero API revenue. Forty companies got access for free. The market read that as a cybersecurity threat. We read it as a business model.